BioRender 图标

Astrocyte (with end feet, one-sided)

Astrocyte (with end feet, one-sided) - Editable icon of Astrocyte (with end feet, one-sided)
[{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b3f/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b3f/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b40/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b40/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b41/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b41/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b42/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b42/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b43/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b43/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b44/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b44/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b45/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b45/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b46/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b46/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b47/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b47/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b48/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b48/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b49/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b49/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b4a/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b4a/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b4b/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b4b/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b4c/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b4c/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b4d/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b4d/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b4e/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b4e/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b4f/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b4f/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b50/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b50/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b51/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b51/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b52/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b52/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b53/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b53/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b54/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b54/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b55/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b55/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b56/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b56/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b57/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b57/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b58/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b58/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b59/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b59/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b5a/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b5a/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b5b/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b5b/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b5c/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b5c/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b5d/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b5d/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b5e/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b5e/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b5f/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b5f/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b60/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b60/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b61/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b61/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b62/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b62/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b63/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b63/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b64/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b64/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b65/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b65/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b66/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b66/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b67/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b67/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b68/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b68/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b69/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b69/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b6a/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b6a/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b6b/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b6b/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b6c/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b6c/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b6d/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b6d/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b6e/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b6e/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b6f/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b6f/5d6e7b852977a50004cbe3c1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d73ed8b6c0cbaec8319b70/5d6e7b852977a50004cbe3c1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d73ed8b6c0cbaec8319b70/5d6e7b852977a50004cbe3c1.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
BBB,blood brain barrier,glial cell,end foot,astrocyte,astrocyte end feet,astrocyte end foot,end foot processes
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Astrocyte (with end feet, one-sided) icon JPEG

Astrocyte (with end feet, one-sided) icon PNG

Astrocyte (with end feet, one-sided) icon SVG

Astrocyte (with end feet, one-sided) icon GIF

BioRender 图标常见问题解答

How are scientists using the Astrocyte (with end feet, one-sided) icon in their work?

BioRender users often use the Astrocyte (with end feet, one-sided) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Astrocyte (with end feet, one-sided) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Astrocyte (with end feet, one-sided) icon customizable in BioRender?

Most icons in BioRender, including the Astrocyte (with end feet, one-sided) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Astrocyte (with end feet, one-sided) icon for publication or presentations?

Yes, figures containing the Astrocyte (with end feet, one-sided) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Astrocyte (with end feet, one-sided) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Astrocyte (with end feet, one-sided) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Astrocyte (with end feet, one-sided) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon